thymidine has been researched along with Hyperparathyroidism, Primary in 1 studies
Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, K | 1 |
| Umino, K | 1 |
| Azuma, Y | 1 |
| Kosaka, S | 1 |
| Takano, K | 1 |
| Obara, T | 1 |
| Sato, K | 1 |
1 other study available for thymidine and Hyperparathyroidism, Primary
| Article | Year |
|---|---|
Stimulating parathyroid cell proliferation and PTH release with phosphate in organ cultures obtained from patients with primary and secondary hyperparathyroidism for a prolonged period.
Topics: Calcium; Cell Proliferation; Gene Expression Regulation; Humans; Hyperparathyroidism, Primary; Hyper | 2009 |